KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review

BACKGROUND: Epidermal growth factor receptor (EGFR) signaling is one of the most promising targets for molecular-targeted therapies in esophageal squamous cell carcinoma (ESCC). Thus, the molecular diagnosis of KRAS and BRAF mutations is clinically important in therapeutic decision making. However,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Shigaki, Hironobu, Baba, Yoshifumi, Watanabe, Masayuki, Miyake, Keisuke, Murata, Asuka, Iwagami, Shiro, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Yoshida, Naoya, Baba, Hideo
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2012
Assuntos:
Translational Research and Biomarkers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853643/
https://ncbi.nlm.nih.gov/pubmed/23274581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-012-2819-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares